OCHAPSIS Trademark

Trademark Overview


On Tuesday, February 7, 2023, a trademark application was filed for OCHAPSIS with the United States Patent and Trademark Office. The USPTO has given the OCHAPSIS trademark a serial number of 97784250. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, January 17, 2024. This trademark is owned by Insmed Incorporated. The OCHAPSIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of sarcoidosis, interstitial lung disease, pulmonary fibrosis, and idiopathic pulmonary fibrosis; Pharmaceutical preparations for the treatment of pulmonary hypertension, pulmonary arterial hypertension (PAH), pulmonary hypertension associated with lung disease, pulmonary hypertension associated with interstitial lung disease (PH-ILD), pulmonary hypertension associated with chronic obstructive pulmonary disease, portopulmonary hypertension, pulmonary hypertension associated with sleep-related breathing disorders, pulmonary hypertension associated with chronic thrombotic and embolic disease, and pulmonary hypertension secondary to hematologic, metabolic, renal, granulomatous, or fibrotic disorders
ochapsis

General Information


Serial Number97784250
Word MarkOCHAPSIS
Filing DateTuesday, February 7, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, January 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 10, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of sarcoidosis, interstitial lung disease, pulmonary fibrosis, and idiopathic pulmonary fibrosis; Pharmaceutical preparations for the treatment of pulmonary hypertension, pulmonary arterial hypertension (PAH), pulmonary hypertension associated with lung disease, pulmonary hypertension associated with interstitial lung disease (PH-ILD), pulmonary hypertension associated with chronic obstructive pulmonary disease, portopulmonary hypertension, pulmonary hypertension associated with sleep-related breathing disorders, pulmonary hypertension associated with chronic thrombotic and embolic disease, and pulmonary hypertension secondary to hematologic, metabolic, renal, granulomatous, or fibrotic disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, February 26, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInsmed Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807

Party NameInsmed Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807

Trademark Events


Event DateEvent Description
Friday, January 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 17, 2024SOU EXTENSION 1 GRANTED
Wednesday, January 17, 2024SOU EXTENSION 1 FILED
Wednesday, January 17, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, December 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 10, 2023PUBLISHED FOR OPPOSITION
Wednesday, September 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 30, 2023ASSIGNED TO EXAMINER
Sunday, February 26, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 10, 2023NEW APPLICATION ENTERED